BioPorto invites investors to October 7 meeting on growth strategy

Verifying
  • BioPorto will host an investor meeting covering commercial progress, clinical opportunities and strategic priorities.
  • The event will take place October 7, 2026, from 3:00 p.m. to 5:30 p.m. CET.
  • BioPorto will present an Adult Clinical Validation Study update and discuss updated KDIGO guidelines.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.